The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

The stock now trades at one of its lowest price-to-earnings ratios in years. The Danish pharmaceutical giant announced it was ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

The S&P 500 and Nasdaq traded near all-time highs at midday as a strong earnings report from Alphabet lifted big tech stocks.

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results from its stage III clinical trial.

Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

Oscar Health (NYSE: OSCR) built on its profitable start to 2025 with a strong first quarter, though emerging challenges in Q2 ...

Trump’s EU trade deal exposes the media’s April tariff freakout—predictions of empty shelves, recession, and market collapse ...

A domestic and international spotlight on tumors In its initial research collaboration with Mass General Brigham, Biostate AI is focusing on melanoma immunotherapy. Specifically, the team's work on ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...